Exploiting the defensive sugars of HIV-1 for drug and vaccine design
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antige...
主要な著者: | Scanlan, C, Offer, J, Zitzmann, N, Dwek, R |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Nature Research
2007
|
類似資料
-
Emerging principles for the therapeutic exploitation of glycosylation.
著者:: Dalziel, M, 等
出版事項: (2014) -
Sugar immunogens
著者:: Dwek, R, 等
出版事項: (2009) -
Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
著者:: Dunlop, D, 等
出版事項: (2008) -
Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
著者:: Dunlop, D, 等
出版事項: (2008) -
Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
著者:: Dunlop, D, 等
出版事項: (2009)